0001231919-25-000671.txt : 20251230 0001231919-25-000671.hdr.sgml : 20251230 20251230155317 ACCESSION NUMBER: 0001231919-25-000671 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251230 DATE AS OF CHANGE: 20251230 EFFECTIVENESS DATE: 20251230 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DMC Biotechnologies, Inc. CENTRAL INDEX KEY: 0001728411 ORGANIZATION NAME: EIN: 471479674 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-568455 FILM NUMBER: 251614101 BUSINESS ADDRESS: STREET 1: 2477 55TH STREET, SUITE 120 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 720-239-7239 MAIL ADDRESS: STREET 1: 2477 55TH STREET, SUITE 120 CITY: BOULDER STATE: CO ZIP: 80301 D 1 primary_doc.xml X0708 D LIVE 0001728411 DMC Biotechnologies, Inc. 2477 55TH STREET, SUITE 120 BOULDER CO COLORADO 80301 720-239-7239 DELAWARE None None Corporation true Jim Flatt c/o DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 Boulder CO COLORADO 80301 Executive Officer Director Rob van der Meij c/o DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 Boulder CO COLORADO 80301 Director Josko Bobanovic c/o DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 Boulder CO COLORADO 80301 Director Doug Cameron c/o DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 Boulder CO COLORADO 80301 Director Alastair Cooper c/o DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 Boulder CO COLORADO 80301 Director Matthew Lipscomb c/o DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 Boulder CO COLORADO 80301 Director K'Lynne Johnson c/o DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 Boulder CO COLORADO 80301 Director Josh Yelen c/o DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 Boulder CO COLORADO 80301 Executive Officer Biotechnology Decline to Disclose 06b false 2025-10-31 false true true true true true Promissory notes convertible into equity securities of the Issuer and the equity securities to be issued upon such conversion false 0 1658250 904500 753750 false 4 0 0 0 false DMC Biotechnologies, Inc. Jim Flatt Jim Flatt Chief Executive Officer 2025-12-30